|Child and Adolescent Psychiatry|
Behavioral Health Workforce Tracker
The tool has no data for psychologists, counselors, and therapists prior to 2020. Changing Year to 2021.
The tool has no data for psychologists, counselors, and therapists prior to 2020. De-selected any psychologists, counselors, and therapists.
The tool has no Rx data for psychologists, counselors, and therapists. "Rx Paid by" and "Drug Type" toogles only apply to physicians and advanced practice providers.
All prescribers are de-selected. All toggles for "Rx Paid by" and "Drug Type" are disabled.
The map uses novel data sources: IQVIA Xponent, to identify prescribers of behavioral health medications (psychiatrists, addiction medicine specialists, primary care physicians, advanced practice providers, and other physicians); and state licensure data, to identify psychologists, licensed clinical social workers, licensed professional counselors, and licensed marriage and family therapists.
Use the Behavioral Health Workforce Tracker to:
- See state variation in the strength of the behavioral health workforce, from 2017 – 2021 for prescribers and 2020 – 2021 for licensed professionals. For example, states with the highest supply of psychiatric and addiction medicine specialists relative to population are in the Northeast. In contrast, the states with the highest supply of counselors and therapists relative to population are concentrated in the mountain states.
- Drill down to the county level to find out if your county had an active psychiatrist or addiction medicine specialist in 2021, as 50% of counties did not.
- Track variation in Medicaid acceptance (as well as Medicare, private insurance, and uninsured) across prescriber types at the state and county level which is important given that nearly one out of five (21%) behavioral health prescribers did not treat Medicaid beneficiaries in 2021.
- See how many clinicians wrote prescriptions for medications indicated for treating serious mental illness (e.g., mood stabilizers or antipsychotics) or medications for opioid use disorder (e.g., buprenorphine or naltrexone) at the state and county level.